Royal Australian Navy - 👉 Bachelor of Electronic and Communications Engineering
Releaf, Business Of Cannabis, CPD, Cannabis Now Magazine, High Times, Cookies Seeds, Fast Buds, MSNL, Paradise Seeds, Premium Cultivars
Sam North is a content writer at Releaf, specialising in medical cannabis, digital health, and patient education within a UK regulatory framework. After a decade immersed in the cultivation side of the cannabis industry, Sam moved into digital in 2020. He worked across the recreational space with seed companies, CBD brands, and cannabis publications, before transitioning into the medical cannabis sector in early 2023 and joining Releaf in April of that year. Today, his work spans both content and SEO, with a focus on how the two support patient understanding and long-term organic growth. He writes and shapes educational content, research breakdowns, and patient-facing web copy, ensuring it is clear, clinically accurate, and aligned with UK compliance requirements. At Releaf, Sam’s focus is on making medical cannabis more understandable and accessible to patients, while maintaining a high standard of accuracy, compliance, and trust.
As we age, the need for medical care and support grows. From decades-long niggles to sudden, serious health concerns - the golden years can be challenging and uncertain. Conventional approaches to health are the go-to for most seniors, but many pharmaceutical options can have heavy, concerning, and risky side effects.
Starting medical cannabis treatment can feel daunting. This guide explains how treatment works in the UK, what information you need to provide, and what happens next, helping you understand the process clearly before your first consultation with Releaf.
With roots stretching back more than two decades, World Panic Day was created to bring attention to the alarming rise in anxiety disorders and the need for improved understanding, support, and treatment. It is a day to educate others about the realities of living with anxiety, to dispel myths and misconceptions, and to promote acceptance.
Life is full of ups and downs, highs and lows, stressful periods, and the odd moment of calm. This rollercoaster of emotions can be even more intense and challenging for university students, as there are just so many things to juggle - exams, assignments, social life, work, family, the pressure of figuring out what to do with your life, or if you have even made the right choice with your chosen academic path.
To launch our New Patient blog series, we're beginning with a beginner's guide that explores the effects of medical cannabis on the body.
In today's article, we are going to put a spotlight on all the medical cannabis oil options that are now legally prescribable here in the UK and take a close look at how they may be able to aid patients in managing symptoms relating to a huge range of health conditions.
With Rare Disease Day upon us, let's take this opportunity to have a look at how certain rare health conditions may benefit from medical cannabis and how medical cannabis has already been prescribed in the UK to treat some rare conditions.
Finding the perfect dosage size for medical cannabis can be tricky. Unlike some traditional medication options, there really is no one-size-fits-all approach.
Weed, ganga, pot, kush, bud, sticky-icky, Mary Jane - whatever term you use, cannabis has been intertwined with the human experience for millennia, and has a rich history in traditional medicine globally. But as the world modernises, cultures clash, and science advances, it has become somewhat of a polarising topic.
International Epilepsy Day 2026 offers a timely look at epilepsy care in the UK. With over 630,000 people affected here in the UK, this guide explains how peoplle with epilepsy can legally acces medical cannabis treatment, along with seizure management research, and how legal frameworks continue to shape treatment options.
The cannabis sativa L. plant has a fascinating and deep-rooted history here in the United Kingdom. A profoundly important and versatile plant in terms of both medicinal application and use in the industrial sector, it has been utilised for various purposes throughout the ages. Without hemp, our country's past would have been quite different indeed.
The private sector can prescribe medical cannabis for a much wider range of health issues than the NHS. There is actually no definitive list of conditions and symptoms that may qualify, as it is up to the discretion of the individual clinician.
How long does cannabis stay in your system? THC can remain detectable in saliva tests for 24-72 hours, urine tests up to 30 days, blood tests for 24 hours, and hair tests up to 90 days
Although most of the clinical research and media attention has focused on cannabinoids (such as THC and CBD), the other compounds found in the cannabis sativa L. plant, such as terpenes, are starting to gain recognition for their potential therapeutic benefits.
Medical cannabis is not a cure for autism. However, there is growing evidence that suggests THC, and medical cannabis more generally, may help in managing some symptoms associated with autism when administered in conjunction with other therapies and interventions.
There is currently no cure for dementia, but a combination of medication, physical therapy, mental stimulation, and lifestyle changes have been shown to help slow the progression of dementia and help to manage the symptoms effectively. One potential complementary treatment option that has shown promise in recent research is CBD, or cannabidiol.
Ever wonder why some CBD oils feel more calming, energising or balanced than others? The answer could lie in the terpene profile. This guide explains what terpenes are, how they shape the effects of CBD oil, and why full-spectrum or broad-spectrum extracts may offer more complete support. We cover common terpenes like myrcene, linalool and limonene, and how to choose a better-quality CBD product by checking lab reports, cannabinoid profiles and extraction methods.
Medical cannabis is finally here in the UK, and it's here to stay. With the UK government legalising medical cannabis in 2018, patients now have access to this complementary treatment option for a vast range of medical conditions, at least when it is prescribed through a private clinic. Unfortunately, since medical cannabis became a reality, securing a prescription for medical cannabis through the NHS is still extremely rare, and is only applicable for three specific conditions.
After decades of lobbying by patient advocates and healthcare professionals, on the 1st of November 2018 here in the UK, medical cannabis became legally available to patients suffering from a huge range of conditions including (but nowhere near limited to) chronic pain, multiple sclerosis, fibromyalgia, epilepsy, mental health concerns, and cancer treatment-related nausea. But with this new availability comes many questions, and these are necessary for the safe application of medical cannabis. In this article, we'll have a closer look at the pros and cons of taking medical cannabis as a complementary treatment option.
Medical cannabis in the UK has grown sharply in recent years, with around 60,000 active patients in 2025 and projections to reach 100,000 before year-end. Access remains uneven, NHS prescriptions are rare, and private clinics carry the load. This guide explores patient numbers, conditions, clinics, access challenges, and how the UK compares internationally.
It is possible to obtain a commercial medical cannabis cultivation licence in the UK, but it is not a straightforward process. Companies looking to produce cannabis-based medicinal products need to seek authorisation from two regulatory bodies – the MHRA and the Home Office. The burgeoning medical cannabis cultivation market has forced some changes to the overall process of applying for these licences.
With the introduction of medical cannabis here in the UK, patients are now able to access cannabis based medical products (CBMPs) in the treatment of pain. And while this is great news for many, the world of CBMPs can be daunting – especially when there are so many cannabinoids at play.
In the UK today, hemp can be legally grown for commercial purposes provided the farmer or grower receives a special licence from the home office. Growers are also only able to cultivate hemp varieties that contain lower than 0.2% THC. This is because cannabis (or more specifically, cannabis plants that contain more than 0.2%THC) is still considered a class B drug.
From a chemical standpoint, THC and CBD are actually isomers. This means that although they have the same chemical formula, their structure differs. They are both classed as phytocannabinoids, or cannabinoids produced by the cannabis plant, but their differences in structure mean that they interact with our body’s receptors in entirely disparate ways – and this is what results in their unique therapeutic properties.
"Since starting my treatment plan with Releaf, I’m genuinely shocked at how well it has worked."Chloe Durrington, Releaf patient
